Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Ma

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cancer Management and Research|April 25, 2017
The clinical development of obinutuzumab for the treatment of follicular lymphomaBarbara Ma, Chaitra Ujjani
The Journal of Investigative Dermatology|November 30, 2021
Immune Checkpoint Blockade and Skin Toxicity PathogenesisBarbara Ma, Niroshana Anandasabapathy
Immunologic Research|January 13, 2010
Therapeutic HPV DNA vaccinesKen Lin, Elena Roosinovich, Barbara Ma, et al.
Therapeutic Delivery|June 29, 2011
HPV pseudovirions as DNA delivery vehiclesBarbara Ma, Richard B S Roden, Chien-Fu Hung, et al.
Cell & Bioscience|July 30, 2011
DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunityShiwen Peng, Barbara Ma, Shu-Hsia Chen, et al.
Expert Opinion on Biological Therapy|March 21, 2008
Therapeutic human papillomavirus vaccines: current clinical trials and future directionsChien-Fu Hung, Barbara Ma, Archana Monie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2009
Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancerChih-Long Chang, Barbara Ma, Xiaowu Pang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 28, 2012
Targeted coating with antigenic peptide renders tumor cells susceptible to CD8(+) T cell-mediated killingTae Heung Kang, Barbara Ma, Connie Wang, et al.
Vaccine|November 29, 2011
LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccinesTong Tong Zhang, Tae Heung Kang, Barbara Ma, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 5, 2010
Immunotherapy for cervical cancer: Research status and clinical potentialJun-Han Su, Anjui Wu, Elizabeth Scotney, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer Management and Research|April 25, 2017
The clinical development of obinutuzumab for the treatment of follicular lymphomaBarbara Ma, Chaitra Ujjani
The Journal of Investigative Dermatology|November 30, 2021
Immune Checkpoint Blockade and Skin Toxicity PathogenesisBarbara Ma, Niroshana Anandasabapathy
Immunologic Research|January 13, 2010
Therapeutic HPV DNA vaccinesKen Lin, Elena Roosinovich, Barbara Ma, et al.
Therapeutic Delivery|June 29, 2011
HPV pseudovirions as DNA delivery vehiclesBarbara Ma, Richard B S Roden, Chien-Fu Hung, et al.
Cell & Bioscience|July 30, 2011
DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunityShiwen Peng, Barbara Ma, Shu-Hsia Chen, et al.
Expert Opinion on Biological Therapy|March 21, 2008
Therapeutic human papillomavirus vaccines: current clinical trials and future directionsChien-Fu Hung, Barbara Ma, Archana Monie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2009
Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancerChih-Long Chang, Barbara Ma, Xiaowu Pang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 28, 2012
Targeted coating with antigenic peptide renders tumor cells susceptible to CD8(+) T cell-mediated killingTae Heung Kang, Barbara Ma, Connie Wang, et al.
Vaccine|November 29, 2011
LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccinesTong Tong Zhang, Tae Heung Kang, Barbara Ma, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 5, 2010
Immunotherapy for cervical cancer: Research status and clinical potentialJun-Han Su, Anjui Wu, Elizabeth Scotney, et al.
Pageof 2